dementia
Centogene, Alector Partner to ID Frontotemporal Dementia Patients With Genetic Mutations
The EFRONT study aims to enroll more than 3,000 FTD patients for genetic testing at centers in Belgium, Germany, Greece, Italy, Portugal, Spain, and Turkey.
CND Life Sciences Wins $2.4M NIH Grant to Develop Synucleinopathy Test
The test is designed to detect and visualize abnormal phosphorylated alpha-synuclein — a hallmark of synucleinopathies — in cutaneous nerve fibers.
Alzheimer's Drug Discovery Foundation Awards $5.5M in Grants for Diagnostic Development
The grants were awarded through the organization's Diagnostic Accelerator, a partnership between the charity and various philanthropic partners.
Biosignatures Closes £3.5M in Funding
The financing, led by Accelerated Digital Ventures, will go toward the development of 20 tests targeted at cancers and dementias.
Alzheimer's Initiative Launches With $30M From Bill Gates, Others
With funding from Bill Gates and others, the Diagnostics Accelerator aims to support the development of new biomarkers for the early detection of Alzheimer's.
Sep 5, 2017